Abstract
Ending the West Africa Ebola virus disease (EVD) outbreak required an unprecedented international response. For the United States, participation in the international response to the West Africa EVD outbreak provided an opportunity to learn important lessons in four key domains critical to preparing for future outbreaks of EVD and other serious communicable diseases: (i) safe and effective patient care, (ii) the role of experimental therapeutics and vaccines, (iii) infection control, and (iv) hospital and community preparedness.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Africa, Western / epidemiology
-
Antibodies, Monoclonal / biosynthesis
-
Antibodies, Monoclonal / therapeutic use
-
Communicable Diseases / epidemiology*
-
Communicable Diseases / transmission
-
Disease Outbreaks / prevention & control*
-
Ebola Vaccines / immunology
-
Ebola Vaccines / therapeutic use
-
Ebolavirus / pathogenicity*
-
Hemorrhagic Fever, Ebola* / epidemiology
-
Hemorrhagic Fever, Ebola* / prevention & control
-
Hemorrhagic Fever, Ebola* / therapy
-
Hemorrhagic Fever, Ebola* / transmission
-
Humans
-
Infection Control / methods*
-
Therapies, Investigational / methods
-
United States / epidemiology
-
Uveitis / microbiology
Substances
-
Antibodies, Monoclonal
-
Ebola Vaccines
-
ZMapp